Adaptive and Group Sequential Clinical Methods for Clinical Trial Design

Add bookmark

Adaptive and Group Sequential Clinical Methods for Clinical Trial Design

Add bookmark

Chris Jennison, Professor of Statistics at the University of Bath, talks to Helen Winsor from Pharma IQ, about adaptive and group sequential clinical methods for clinical trial design and how important group sequential design is to clinical trials. Jennison also shares his insights on the vital considerations in sample size re-estimation for updated estimates of response variance and where clinical trials headed in the future. Haven’t got the technology to listen to the podcast? Read the interview here Is Adaptive Design just a Buzzword Solution?
[inlinead]


Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended